Skip to content

Effect of baduanjin on cognitive function and quality of life in breast cancer patients undergoing chemotherapy: a randomized controlled trial.

Effect of baduanjin on cognitive function and quality of life in breast cancer patients undergoing chemotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003324
Enrollment
Unknown
Registered
2020-05-22
Start date
2020-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Sponsors

The Seventh People's Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) female patients newly diagnosed stage I to III breast cancer; (2) schedule to receive adjuvant chemotherapy; (3) aged 40 to 75 years; (4) sufficient fluency of the Chinese language; and (5) willing to participate in the study and be randomly assigned

Exclusion criteria

Exclusion criteria: (1) disease recurrence or metastasis; (2) known conditions and/or diseases that impact cognition (eg, Alzheimers disease, dementia, or other psychological diagnoses); (3) disorders that might preclude exercise participation (eg, fracture, arthritis); and (4) current/planned participation in mindfulness-based exercise programs (eg, TaiChi or Qigong).

Design outcomes

Primary

MeasureTime frame
Hopkins Verbal Learning Test-Revised;Trial Making Test;Functional Assessment of Cancer Therapy-Cognitive Function;

Secondary

MeasureTime frame
Functional Assessment of Cancer Therapy-Breast;

Countries

China

Contacts

Public ContactShu Li
251689038@qq.com+86 13402024617

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026